![How South Korea Became a Leading Destination for Clinical Trials](https://www.precisionformedicine.com/hs-fs/hubfs/How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg?width=396&height=224&name=How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg)
![Category Hero Image](https://www.precisionformedicine.com/hs-fs/hubfs/PfMxMarkentive/images/category_03_01.webp?width=1440&height=672&name=category_03_01.webp)
![image 35](https://www.precisionformedicine.com/hs-fs/hubfs/image%2035.png?width=850&height=1440&name=image%2035.png)
Execute Clinical Trial Feasibility with Precision
Optimize your study's initiation through precise country and site selection, powered by actionable insights.
Proceed with Precision
At Precision, our feasibility process is more than just a preliminary step; it's a critical foundation for the success of your clinical trial. By focusing on strategic site selection and in-depth insights gathering, we ensure your study starts with a significant advantage.
![iStock-876250496](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/PfM%20-%20Clinical%20Trial%20Services/Clinical%20trial%20feasibility/iStock-876250496.webp?width=1200&height=1543&name=iStock-876250496.webp)
Plan for success with Site Feasibility
Site feasibility is the cornerstone of clinical trial planning, acting as the bridge between groundbreaking research and its successful execution. Understanding the pivotal role of site feasibility ensures a solid foundation for any clinical study. It's not merely about identifying potential sites but about strategic alignment with the trial's objectives, patient populations, and operational capacities. This proactive approach to site selection, grounded in data-driven insights and comprehensive evaluations, mitigates risks and sets the stage for successful patient enrollment and study outcomes.
Roughly 80% of clinical trials fail to meet original enrollment timelines, and about one-third of Phase III study terminations are due to enrollment difficulties. Additionally, 15% to 20% of sites never enroll a single patient.
Given these statistics, it's evident that conducting a comprehensive feasibility study is essential for avoiding common pitfalls like poor enrollment and sites that never enroll. Precision's feasibility team employs multiple methods to ensure a sponsor's needs are met, tailoring our approach to each unique trial. This adaptability, combined with a deep understanding of the intricacies of clinical trials, allows Precision to navigate complex requirements and ensure trials are set up for success from the start.
Precision's Clinical Trial Feasibility process overview
Step 1
Initial Planning
- Understand study objectives
- Identify target countries/sites
- Develop feasibility questionnaire
- Augment site list with Precision/external data
- Site list finalized for feasibility start
Step 2
Data Collection & Analysis
- Distribute questionnaires
- Pursue sites for response
- Collect sites responses
- Evaluate sites performance
- Prepare feasibility report
- Review report with client
- Filter out low-potential sites
Step 3
Recruitment Modeling
- Develop enrollment scenarios
- Estimate recruitment timelines
- Project patient numbers
- Adjust site requirements
- Plan for contingencies
- Present models to clients
Step 4
Site Selection & Verification
- Confirm top-performing sites
- Schedule pre-study visits
- Verify site infrastructure
- Assess staff expertise
- Determine recruitment potential
- Finalize site list for activation
- Finalize back-up site list
Step 5
Performance Monitoring
- Regular progress check-ins
- Address emerging issues
- Adjust recruitment plans
- Activate backup sites
- Ensure timeline adherence
- Provide ongoing support
Precision’s strategic approach to clinical trial feasibility
![](https://www.precisionformedicine.com/hs-fs/hubfs/Image%2047%20(2).png?width=313&height=376&name=Image%2047%20(2).png)
![](https://www.precisionformedicine.com/hs-fs/hubfs/Image%2047%20(2).png?width=313&height=376&name=Image%2047%20(2).png)
![](https://www.precisionformedicine.com/hs-fs/hubfs/Image%2047%20(2).png?width=313&height=376&name=Image%2047%20(2).png)
Our approach to site feasibility is both comprehensive and meticulous. By integrating broad data analysis with site-specific insights, we ensure each trial starts on the best possible footing. Our process begins with understanding study objectives and identifying optimal countries and sites, followed by developing and distributing targeted feasibility questionnaires. We then analyze site responses and performance, preparing detailed feasibility reports for client review. Through recruitment modeling, we project patient numbers and timelines, allowing for adjustments and contingency planning. Site selection is confirmed through pre-study visits and infrastructure verification, with backup sites identified for risk mitigation. Continuous performance monitoring ensures adherence to timelines and proactive issue resolution, backed by ongoing support. This strategic and detailed approach enables our sponsors to navigate trial complexities with confidence, ensuring successful study execution.
Our site feasibility services can be executed as standalone projects, during pre-study phases, or integrated into full study start-up processes. This flexibility allows us to adapt to each sponsor's unique requirements, providing tailored support that aligns with their specific clinical trial needs.
![](https://www.precisionformedicine.com/hs-fs/hubfs/Image%2047%20(2).png?width=313&height=376&name=Image%2047%20(2).png)
![](https://www.precisionformedicine.com/hs-fs/hubfs/Image%2047%20(2).png?width=313&height=376&name=Image%2047%20(2).png)
![](https://www.precisionformedicine.com/hs-fs/hubfs/Image%2047%20(2).png?width=313&height=376&name=Image%2047%20(2).png)
-
Precision for Medicine stands out for partnership and versatility. Everything has been completed on time, and we are looking forward to applying the lessons we learned here to future analysis endpoints.
— Vice President, Clinical Operations, Midsize Biotech -
We have been delighted with the experience level and work product from the entire project team – they feel like an extension of our internal team.
— Director, Midsize Pharma -
I recognize that relations between Sponsors and CRO vendors can be strained and difficult, often a blaming game; this has never been my experience with this group as it truly felt like a partnership.
— Director, Small Biotech -
Our partnership with Precision is a true textbook definition of a great collaboration between a sponsor and a CRO.
— Senior Director, Midsize Biotech
Insights from Precision’s experts
Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to navigate early and late phase development.
![How South Korea Became a Leading Destination for Clinical Trials](https://www.precisionformedicine.com/hs-fs/hubfs/How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg?width=396&height=224&name=How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg)
How South Korea Became a Leading Destination for Clinical Trials
![Clinical Trial Trends: Multiple Myeloma](https://www.precisionformedicine.com/hs-fs/hubfs/Clinical%20Trial%20Trends%20-%20Miultiple%20Myeloma.jpg?width=396&height=224&name=Clinical%20Trial%20Trends%20-%20Miultiple%20Myeloma.jpg)
![AI's Role in Reshaping Drug Development: FDA Workshop Recap](https://www.precisionformedicine.com/hs-fs/hubfs/AIs%20Role%20in%20Reshaping%20Drug%20Development.jpg?width=396&height=224&name=AIs%20Role%20in%20Reshaping%20Drug%20Development.jpg)
Advance therapeutic breakthroughs with Precision
Explore the breadth of our expertise in therapeutics and modalities, as we lead your novel treatments in Oncology, Rare Diseases and beyond, from the groundbreaking idea to clinical realization.
Clinical trial excellence: Precision in all phases
With people across 70+ countries, our team provides comprehensive clinical trial services that streamline and accelerate drug development at a global scale
-
Explore
Early Phase Excellence
Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy. -
Explore
Late Phase Success
Discover the path to market with our Late Phase Development expertise – delivering precision, scale, and efficiency for your clinical journey.
Specialized capabilities in every stage of clinical development
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.
-
Global CRO
ServicesAward-winning CRO with deep oncology and rare disease expertise
-
Global Laboratory
ServicesExceptional translational and biomarker sciences with global central lab services
-
Manufacturing
SolutionsPioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.
-
Biospecimens
-
Diagnostics & CDx
-
Data Intelligence
-
Commercialization
![Img-biologie-cta](https://www.precisionformedicine.com/hs-fs/hubfs/Img-biologie-cta.jpg?width=1440&height=460&name=Img-biologie-cta.jpg)